Why Do People Take Fentanyl: Medical Use and Misuse

People take fentanyl for two fundamentally different reasons. In medicine, it remains one of the most widely used opioids for surgical anesthesia, cancer pain, and acute emergencies. Outside of medicine, fentanyl has flooded the illicit drug supply so thoroughly that many people consume it without choosing it or even knowing it is there. The gap between these two realities explains much of the confusion around fentanyl, and understanding both sides is necessary to make sense of why one drug can be simultaneously indispensable in a hospital and devastating on the street.

Fentanyl in Medicine

Fentanyl was first synthesized in the early 1960s, and despite decades of newer opioid development, it is still the most popular opioid used during surgery worldwide. Anesthesiologists favor it because of its rapid onset, short duration of action, and predictable dose response. Its versatility has led to dozens of delivery methods, from intravenous injection in operating rooms to patches, lozenges, nasal sprays, and sublingual tablets for chronic and breakthrough pain.¹

Cancer patients, particularly those in palliative care, are among the clearest cases for legitimate fentanyl use. Breakthrough cancer pain, the sudden flares that punch through a patient’s baseline pain management, can be excruciating and unpredictable. Transmucosal formulations of fentanyl (absorbed through the lining of the mouth or nose) give relief in minutes rather than the half-hour or more that oral painkillers require.² Studies in palliative care units have found that even low-dose sublingual fentanyl can meaningfully improve quality of life for advanced cancer patients dealing with these flares.³

Emergency medicine has also adopted fentanyl, particularly in its intranasal form. Needle-free nasal sprays offer rapid pain control for both children and adults in pre-hospital settings and emergency departments. Systematic reviews have confirmed intranasal fentanyl to be safe and effective across age groups, including children as young as one to three years old.⁴ For paramedics treating a child with a broken limb, being able to spray pain relief into a nostril rather than start an IV in a moving ambulance is a meaningful clinical advantage.

What Makes Fentanyl So Potent

Fentanyl is roughly 50 to 100 times more potent than morphine by weight. That potency comes from its molecular structure. The drug is highly fat-soluble, which means it crosses from the bloodstream into the brain faster than most opioids. Once there, it activates the mu-opioid receptor, the same target morphine hits, but it does so with a tighter grip. Research has shown that fentanyl can bind to the receptor in ways that morphine-like drugs cannot, reaching a deeper binding pocket on the receptor involving a specific amino acid that modulates how strongly the receptor responds.⁵

This same potency is what makes fentanyl so dangerous outside controlled medical settings. In a hospital, the dose is carefully calibrated by weight and patient history. On the street, there is no such precision. A grain-of-sand-sized difference in the amount of fentanyl in a pill or a bag of powder can be the difference between getting high and stopping breathing.

How Prescription Opioids Led People to Fentanyl

The path from medical use to illicit fentanyl is rarely a straight line from doctor to dealer. For many people, it began with prescription opioids like oxycodone or hydrocodone prescribed for pain. When policy changes starting around 2010 made those prescriptions harder to get, and prescription drug monitoring programs tracked patients more closely, pills became scarcer and more expensive on the street. Qualitative research with people who use drugs has documented this gradual squeeze: doctors became less likely to prescribe, street prices for pills climbed, and people shifted to cheaper alternatives like heroin.⁶

Then fentanyl swept through the heroin supply. Because it is cheap to manufacture and extraordinarily potent by weight, drug suppliers could stretch their product further by mixing in fentanyl or replacing heroin with it entirely. For people already dependent on opioids, this meant they were suddenly exposed to a far more powerful substance. Research into how people first encountered fentanyl has found that most were unaware they were initiating fentanyl use at all, and many overdosed the very first time.⁷ Some people reached fentanyl without ever going through heroin, jumping directly from prescription pills to what turned out to be fentanyl sold as something else.

When People Don’t Know They’re Taking Fentanyl

One of the most alarming aspects of the current crisis is that a large share of fentanyl exposure is unintentional. A study across seven U.S. states found that among people who tested positive for fentanyl, roughly 30% did not know they had been exposed to it.⁸ These were not people seeking fentanyl; they were people using other drugs who unknowingly consumed fentanyl mixed in with or substituted for whatever they thought they were buying.

Counterfeit pills are a major vehicle for this exposure. Analysis of drug seizures in the U.S. found that over a quarter of fentanyl seizures were in pill form, often pressed to look identical to legitimate pharmaceutical tablets like oxycodone or alprazolam (Xanax).⁹ Someone who thinks they are buying a prescription painkiller or anti-anxiety pill from a non-pharmacy source may instead get a tablet containing nothing but fentanyl and filler. The dose in these counterfeit pills is wildly inconsistent, even within the same batch. Two pills from the same bag can contain drastically different amounts.

The Self-Medication Cycle

For people who do knowingly seek out fentanyl, mental health is often part of the picture. Untreated depression, anxiety, or post-traumatic stress disorder can drive people toward substances that offer temporary relief from emotional pain. Fentanyl’s intense but short-lived euphoria and its ability to numb both physical and psychological suffering make it effective at silencing distress, if only for minutes. When the drug wears off, the underlying condition remains or worsens, and the pull toward using again becomes stronger. Over time, the brain’s reward circuitry adapts to the drug, creating physical dependence on top of the psychological one.¹⁰

This self-medication dynamic is not unique to fentanyl, but fentanyl makes it more dangerous. Its potency means tolerance builds fast. Someone who started by chasing emotional numbness can become physically dependent within days or weeks, far quicker than with weaker opioids. Fentanyl’s fat solubility means it accumulates in body tissues and releases slowly, which complicates both the experience of withdrawal and clinical treatment.¹¹

Why Fentanyl Overdoses Are Especially Lethal

All opioids can suppress breathing. That is the primary mechanism of opioid overdose death: the brainstem stops sending adequate signals to the lungs, and the person suffocates. Fentanyl does this more aggressively than most opioids because of its potency, but it also has a second, lesser-known trick that makes it more dangerous than its mu-opioid receptor activity alone would predict.

The phenomenon is called wooden chest syndrome. In addition to suppressing the brain’s breathing drive, fentanyl can cause the muscles of the chest wall and diaphragm to become rigid, making it physically difficult or impossible to move air into and out of the lungs. It was originally described in surgical settings as a rare complication of intravenous fentanyl, and for years it was mainly a concern for anesthesiologists.¹² But in the context of street-level overdoses, where doses are uncontrolled and emergency response may be delayed, this rigidity can be fatal even if naloxone (the opioid-reversal drug) is administered quickly.

Recent research has begun to uncover why this happens. A 2025 study found that fentanyl directly blocks a class of potassium channels in the motor neurons that control the diaphragm. This is not a mu-opioid receptor effect at all; it is an entirely separate, off-target mechanism. The blockade causes these motor neurons to fire continuously, locking the diaphragm into a contracted state. Morphine did not produce this effect in the same experiments.¹³ This matters because naloxone only reverses opioid receptor activity. If part of the respiratory failure is caused by a non-opioid mechanism, naloxone alone may not be enough. Experimental approaches are now exploring combination treatments, pairing naloxone with drugs that target breathing through entirely different pathways.¹⁴

Why Starting Treatment Is Harder with Fentanyl

Buprenorphine is one of the most effective medications for opioid use disorder. It partially activates the opioid receptor, relieving cravings and withdrawal without producing the intense high of full opioids. For decades, the standard approach has been to wait until a patient is in moderate withdrawal before starting buprenorphine, so the drug does not compete with whatever opioid is already on the receptor and trigger a sudden, severe withdrawal reaction.

Fentanyl has disrupted this standard. Because fentanyl is so fat-soluble, it accumulates in body fat and releases slowly over days. Even after someone stops using, fentanyl can continue leaking out of tissue stores and occupying opioid receptors for much longer than heroin or prescription pills would. When buprenorphine is then administered, it can displace the lingering fentanyl and trigger precipitated withdrawal, a rapid-onset, intensely unpleasant syndrome that can include severe vomiting, diarrhea, agitation, and pain.¹⁵

A study of hospitalized patients found that about 16% of those with confirmed fentanyl use experienced precipitated withdrawal after receiving buprenorphine. Higher body mass index and higher urinary fentanyl concentrations both raised the odds substantially. Patients with a BMI of 30 or above had roughly five times the odds of precipitated withdrawal compared to leaner patients, likely because more body fat means more fentanyl stored in tissue.¹⁶ This has made clinicians and patients alike wary of starting buprenorphine, sometimes to the point of avoiding it altogether. Some emergency department cases labeled as precipitated withdrawal may actually represent undertreated or worsening withdrawal that was misattributed, further muddying the picture for clinicians trying to help.¹⁷

Harm Reduction Tools and Their Limits

Fentanyl test strips are inexpensive paper strips that detect fentanyl in a drug sample. They were originally designed for urine testing but have been repurposed as a harm reduction tool. The idea is simple: if you know your drugs contain fentanyl, you can adjust your behavior, use less, avoid mixing substances, or have naloxone nearby. In a British Columbia program, when test strips detected fentanyl, about 27% of people reported changing their behavior in ways considered safer, and over 95% said they would use the strips again.¹⁸

The evidence that test strips actually reduce overdoses and deaths is thinner than many advocates acknowledge. A scoping review found only limited data linking fentanyl test strip use to decreased overdose rates or mortality.¹⁹ Strips tell you whether fentanyl is present, but they cannot tell you how much, and in many markets fentanyl is so widespread that a positive result is almost guaranteed, reducing the practical value of the information. The strips also cannot detect every fentanyl analogue or newer synthetic opioids. They are a useful tool, not a solution, and the gap between their appeal as a concept and the evidence for their impact on mortality is worth being honest about.

What Else Is in the Supply

Fentanyl itself is no longer the only concern in the illicit drug supply. Xylazine, a veterinary sedative never approved for human use, has been turning up mixed with fentanyl across the U.S. Wastewater surveillance in Texas found that every sample collected on xylazine-positive days also tested positive for fentanyl metabolites, and communities with higher xylazine levels had significantly higher fentanyl loads.²⁰ Xylazine is not an opioid, which means naloxone does nothing to reverse its effects. People who overdose on a fentanyl-xylazine combination may not respond to naloxone the way bystanders or first responders expect. Xylazine also causes severe, hard-to-heal skin wounds at injection sites, a complication that has overwhelmed wound care services in cities where the drug is most common.

Beyond xylazine, an even more potent class of synthetic opioids called nitazenes has begun appearing in the drug supply. Structurally unrelated to fentanyl, some nitazene compounds are many times more potent. Their emergence represents a potential shift in the crisis, because the regulatory and law enforcement strategies built to target fentanyl’s chemical structure may not apply to them.²¹ Nitazene-linked deaths have already been documented in the U.S., Canada, and Europe, though fentanyl still dominates by volume.²²

Fentanyl-Related Compounds in Veterinary Medicine

One corner of fentanyl’s legitimate use that the public rarely hears about is veterinary medicine. Carfentanil, a fentanyl analogue roughly 100 times more potent than fentanyl itself, has been used for decades to immobilize large animals. Wildlife biologists use it to sedate deer, elk, and bears for tagging and research. A study on captive white-tailed deer used carfentanil at doses measured in millionths of a gram per kilogram of body weight, paired with another sedative for safe immobilization.²³ Carfentanil’s extreme potency means that an amount invisible to the naked eye can be lethal to a human, and its occasional appearance in the illicit drug supply has caused cluster overdose events.

Why Fentanyl Levels Are Hard to Interpret After Death

When someone dies and fentanyl is found in their system, determining whether it caused the death is more complicated than it seems. Fentanyl undergoes postmortem redistribution, meaning its concentration in the blood changes after death as it leaks from organs and fat tissue into surrounding blood vessels. Blood drawn from different body sites during autopsy can yield very different concentration readings, and the numbers can shift depending on how much time passes between death and sample collection.²⁴ Forensic studies have also found variability between laboratories testing the same samples.²⁵ This means that a fentanyl blood level reported on a death certificate may overstate or understate the person’s actual exposure at the time of death. It also means that comparing fentanyl concentrations between cases to establish a “lethal threshold” is unreliable. Forensic pathologists who work with fentanyl cases understand these limitations, but they can complicate legal proceedings and public health statistics alike.

Regulatory Moves and the Whack-a-Mole Problem

In 2018, the U.S. Drug Enforcement Administration took the unusual step of temporarily scheduling all fentanyl-related substances as a class, rather than chasing individual analogues one at a time. Before this, illicit chemists could tweak fentanyl’s molecular structure just enough to produce a technically legal compound with similar effects. The class-wide scheduling prompted China, then the primary source country, to implement similar controls. The result was a sharp drop in the number of fentanyl analogues appearing in the marketplace, though fentanyl itself continued to increase.²⁶ The same chemical flexibility that made fentanyl analogues possible is now playing out with nitazenes and other structurally distinct opioids. Scheduling fentanyl-related substances was effective for what it targeted, but the broader lesson is that synthetic drugs can be redesigned faster than regulations can follow.